Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer : a case report
BACKGROUND: Accurate diagnosis of metastatic tumors in the breast is crucial because the therapeutic approach is essentially different from primary tumors. A key morphological feature of metastatic tumors is their lack of an in situ carcinoma component. Here, we present a unique case of metastatic ovarian carcinoma spreading into mammary ducts and mimicked an in situ component of primary carcinoma. To our knowledge, this is the second case (and the first adult case) confirming the in situ-mimicking growth pattern of a metastatic tumor using immunohistochemistry.
CASE PRESENTATION: A 69-year-old Japanese woman was found to have a breast mass with microcalcifications. She had a known history of ovarian mixed serous and endocervical-type mucinous (seromucinous) carcinoma. Needle biopsy specimen of the breast tumor revealed adenocarcinoma displaying an in situ-looking tubular architecture in addition to invasive micropapillary and papillary architectures with psammoma bodies. From these morphological features, metastatic serous carcinoma and invasive micropapillary carcinoma of breast origin were both suspected. In immunohistochemistry, the cancer cells were immunoreactive for WT1, PAX8, and CA125, and negative for GATA3, mammaglobin, and gross cystic disease fluid protein-15. Therefore, the breast tumor was diagnosed to be metastatic ovarian serous carcinoma. The in situ-looking architecture showed the same immunophenotype, but was surrounded by myoepithelium confirmed by immunohistochemistry (e.g. p63, cytokeratin 14, CD10). Thus, the histogenesis of the in situ-like tubular foci was could be explained by the spread of metastatic ovarian cancer cells into existing mammary ducts.
CONCLUSION: Metastatic tumors may spread into mammary duct units and mimic an in situ carcinoma component of primary breast cancer. This in situ-mimicking growth pattern can be a potential pitfall in establishing a correct diagnosis of metastasis to the breast. A panel of breast-related and extramammary organ/tumor-specific immunohistochemical markers may be helpful in distinguishing metastatic tumors from primary tumors.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
Journal of medical case reports - 15(2021), 1 vom: 17. Feb., Seite 78 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Maeshima, Yurina [VerfasserIn] |
---|
Links: |
---|
Themen: |
Breast metastasis |
---|
Anmerkungen: |
Date Completed 24.02.2021 Date Revised 24.02.2021 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/s13256-020-02653-w |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM321524233 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM321524233 | ||
003 | DE-627 | ||
005 | 20231225180004.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s13256-020-02653-w |2 doi | |
028 | 5 | 2 | |a pubmed24n1071.xml |
035 | |a (DE-627)NLM321524233 | ||
035 | |a (NLM)33593410 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Maeshima, Yurina |e verfasserin |4 aut | |
245 | 1 | 0 | |a Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer |b a case report |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 24.02.2021 | ||
500 | |a Date Revised 24.02.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: Accurate diagnosis of metastatic tumors in the breast is crucial because the therapeutic approach is essentially different from primary tumors. A key morphological feature of metastatic tumors is their lack of an in situ carcinoma component. Here, we present a unique case of metastatic ovarian carcinoma spreading into mammary ducts and mimicked an in situ component of primary carcinoma. To our knowledge, this is the second case (and the first adult case) confirming the in situ-mimicking growth pattern of a metastatic tumor using immunohistochemistry | ||
520 | |a CASE PRESENTATION: A 69-year-old Japanese woman was found to have a breast mass with microcalcifications. She had a known history of ovarian mixed serous and endocervical-type mucinous (seromucinous) carcinoma. Needle biopsy specimen of the breast tumor revealed adenocarcinoma displaying an in situ-looking tubular architecture in addition to invasive micropapillary and papillary architectures with psammoma bodies. From these morphological features, metastatic serous carcinoma and invasive micropapillary carcinoma of breast origin were both suspected. In immunohistochemistry, the cancer cells were immunoreactive for WT1, PAX8, and CA125, and negative for GATA3, mammaglobin, and gross cystic disease fluid protein-15. Therefore, the breast tumor was diagnosed to be metastatic ovarian serous carcinoma. The in situ-looking architecture showed the same immunophenotype, but was surrounded by myoepithelium confirmed by immunohistochemistry (e.g. p63, cytokeratin 14, CD10). Thus, the histogenesis of the in situ-like tubular foci was could be explained by the spread of metastatic ovarian cancer cells into existing mammary ducts | ||
520 | |a CONCLUSION: Metastatic tumors may spread into mammary duct units and mimic an in situ carcinoma component of primary breast cancer. This in situ-mimicking growth pattern can be a potential pitfall in establishing a correct diagnosis of metastasis to the breast. A panel of breast-related and extramammary organ/tumor-specific immunohistochemical markers may be helpful in distinguishing metastatic tumors from primary tumors | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Breast metastasis | |
650 | 4 | |a Case report | |
650 | 4 | |a In situ component | |
650 | 4 | |a Invasive micropapillary carcinoma | |
650 | 4 | |a Ovarian serous carcinoma | |
700 | 1 | |a Osako, Tomo |e verfasserin |4 aut | |
700 | 1 | |a Morizono, Hidetomo |e verfasserin |4 aut | |
700 | 1 | |a Yunokawa, Mayu |e verfasserin |4 aut | |
700 | 1 | |a Miyagi, Yumi |e verfasserin |4 aut | |
700 | 1 | |a Kikuchi, Mari |e verfasserin |4 aut | |
700 | 1 | |a Ueno, Takayuki |e verfasserin |4 aut | |
700 | 1 | |a Ohno, Shinji |e verfasserin |4 aut | |
700 | 1 | |a Akiyama, Futoshi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of medical case reports |d 2007 |g 15(2021), 1 vom: 17. Feb., Seite 78 |w (DE-627)NLM169450775 |x 1752-1947 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2021 |g number:1 |g day:17 |g month:02 |g pages:78 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13256-020-02653-w |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 15 |j 2021 |e 1 |b 17 |c 02 |h 78 |